THE KAMEN LAB
Department of Bioengineering, McGill University
Welcome to the McGill University Kamen Lab!
Vaccines are one of the most effective ways to reduce illness and death caused by infectious diseases. We often associate vaccines with childhood, but new vaccination strategies have the potential to protect adults from cancer and chronic diseases. This is thanks to emerging technology that helps turn recombinant viruses (formed by recombining genetic material) and RNA into antigens and immunotherapeutics. An antigen is any substance that activates the immune system for protection through antibody production and eventually long-term cellular response. Research in these areas is expanding rapidly.
For these emerging technologies to have an impact, we need to be able to make them. For that, we need access to production and purification processes that meet the highest standards for manufacturing biologics, using cutting-edge biotechnologies on a scale large enough for clinical evaluation.
About the PI
Learn more about Amine Kamen and the work they've done to contribute to the McGill space.
We are welcoming post-doc candidates. Click here for more information.
Latest updates
Congratulations to Faizul on his successful PhD defense!
Vaccine Technology X Conference
Porto, Portugal
Vaccine Technology IX Conference
Los Cabos, Mexico
Our partners
